scholarly article | Q13442814 |
P50 | author | Jorge A. Carrasquillo | Q40015819 |
Ahmed M. Gharib | Q51235824 | ||
Lynnette K Nieman | Q89274223 | ||
P2093 | author name string | Ninet Sinaii | |
Clara C Chen | |||
Millie Whatley | |||
Iffat Chowdhury | |||
Bhaskar Gundabolu | |||
Marina S Zemskova | |||
P2860 | cites work | Two-sided confidence intervals for the single proportion: comparison of seven methods | Q28271313 |
Ectopic adrenocorticotropic hormone syndrome: localization studies in 28 patients. | Q30873010 | ||
Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production | Q34162762 | ||
The Cushing Syndrome Induced by Bronchial Carcinoid Tumors | Q35229481 | ||
Differential diagnosis and imaging in Cushing's syndrome | Q36105809 | ||
The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. | Q36320010 | ||
Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study | Q40292210 | ||
Ectopic adrenocorticotropic hormone syndrome | Q40500001 | ||
Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome | Q42462984 | ||
Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors | Q43690572 | ||
Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumours. Correlation with preoperative octreotide scintigraphy | Q43852214 | ||
The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome | Q44883255 | ||
Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health | Q46508241 | ||
Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours. | Q53485156 | ||
Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients. | Q53503895 | ||
Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors? | Q53521560 | ||
18F-DOPA PET/CT and neuroendocrine tumours. | Q53524293 | ||
18Flurodeoxyglucose positron emission tomography in the localization of ectopic ACTH-secreting neuroendocrine tumours. | Q53544054 | ||
Cushing's syndrome | Q56228192 | ||
Occult ectopic secretion of corticotropin | Q70042087 | ||
Somatostatin analogue scintigraphy in carcinoid tumours | Q70709899 | ||
Tumor localization--the ectopic ACTH syndrome | Q77312488 | ||
A reappraisal of the utility of somatostatin receptor scintigraphy in patients with ectopic adrenocorticotropin Cushing's syndrome | Q79161537 | ||
Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma | Q80406302 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 13 | |
P304 | page(s) | 1207-1219 | |
P577 | publication date | 2010-01-20 | |
P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
P1476 | title | Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors | |
P478 | volume | 95 |
Q38082417 | 18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type |
Q90473498 | 68Ga-DOTATOC PET/CT in detecting neuroendocrine tumours responsible for initial or recurrent paraneoplastic Cushing's syndrome |
Q33774616 | A Case of Pulmonary Carcinoid Tumor with a Superimposed Aspergilloma Presenting As a Covert Ectopic Adrenocorticotropic Hormone Syndrome |
Q34562501 | A challenging case of an ectopic cushing syndrome. |
Q37623490 | Bowel perforation complicating an ACTH-secreting phaeochromocytoma |
Q47151266 | Case report: Ectopic Cushing's syndrome in a young male with hidden lung carcinoid tumor |
Q42816931 | Clinical features and management of ectopic ACTH syndrome at a single institute in Japan |
Q36664008 | Comparative Analysis of Clinical, Hormonal and Morphological Studies in Patients with Neuroendocrine ACTH-Producing Tumours. |
Q37212932 | Comparison of 68Ga-DOTANOC PET/CT and contrast-enhanced CT in localisation of tumours in ectopic ACTH syndrome |
Q36060458 | Conventional and Nuclear Medicine Imaging in Ectopic Cushing's Syndrome: A Systematic Review |
Q35853776 | Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion from a Meckel diverticulum neuroendocrine tumor: case report |
Q28262360 | Cushing's syndrome |
Q35531889 | Cushing's syndrome: epidemiology and developments in disease management |
Q38284048 | Cushing's syndrome: from physiological principles to diagnosis and clinical care |
Q35580706 | Diagnosis of Cushing's disease. |
Q36157161 | Diagnosis of an ectopic adrenocorticotropic hormonesecreting bronchial carcinoid by somatostatin receptor scintigraphy |
Q58005428 | Diagnostic accuracy of [18F]DOPA PET and PET/CT in patients with neuroendocrine tumors: a meta-analysis |
Q40169381 | Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH-dependent Cushing's syndrome. |
Q36817194 | Hypercortisolism is associated with increased coronary arterial atherosclerosis: analysis of noninvasive coronary angiography using multidetector computerized tomography. |
Q49353240 | Is there a clinical usefulness for radiolabeled somatostatin analogues beyond the consolidated role in NETs? |
Q35182968 | Mid-gut ACTH-secreting neuroendocrine tumor unmasked with (18)F-dihydroxyphenylalanine-positron emission tomography. |
Q35744515 | Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing's syndrome due to ectopic adrenocorticotropin secretion |
Q36069747 | Neuroendocrine ACTH-producing tumor of the thymus--experience with 12 patients over 25 years |
Q41839681 | Nuclear medicine imaging in the evaluation of endocrine hypertension |
Q38553374 | PET imaging in ectopic Cushing syndrome: a systematic review |
Q28830414 | Paraneoplastic Cushing's syndrome associated with bronchopulmonary carcinoid tumor in youth: A case report and review of the literature |
Q34431162 | Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia |
Q37098639 | Prolonged remission after long-term treatment with steroidogenesis inhibitors in Cushing's syndrome caused by ectopic ACTH secretion |
Q40632126 | Recommendations of the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism for the diagnosis of Cushing's disease in Brazil. |
Q42871101 | Successful localization of ectopic ACTH-secreting bronchial carcinoid by selective pulmonary arterial sampling |
Q37137705 | The value of somatostatin receptor imaging with In-111 Octreotide and/or Ga-68 DOTATATE in localizing Ectopic ACTH producing tumors |